170 related articles for article (PubMed ID: 32536986)
1. Efficacy and safety of leflunomide
Ying S; Xiaomeng C; Xiaomin D; Jiang L; Peng L; Lili M; Rongyi C; Zongfei J; Huiyong C; Lindi J
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20930114. PubMed ID: 32536986
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort.
Cui X; Dai X; Ma L; Yang C; Tan W; Zhang L; Zhang Z; Feng X; Wu R; Zou Y; Zhou Z; Lu Y; Wang Y; Wu M; Li S; Wang L; Lin H; Dong Z; Fu W; Sun X; Wang C; Ding J; Lv P; Lin J; Jiang L;
Semin Arthritis Rheum; 2020 Feb; 50(1):59-65. PubMed ID: 31350057
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study.
Dai X; Cui X; Sun Y; Ma L; Jiang L
Ther Adv Chronic Dis; 2020; 11():2040622320922019. PubMed ID: 32551033
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and safety of methotrexate
Wu C; Sun Y; Cui X; Wu S; Ma L; Chen H; Yan Y; Ji Z; Liu Y; Lin J; Lv P; Chen R; Yang P; Jiang L
Ther Adv Chronic Dis; 2020; 11():2040622320975233. PubMed ID: 33294149
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study.
Wang J; Dai X; Ma L; Wu S; Jin X; Ji Z; Chen H; Ma L; Ding Z; Jiang L; Kong X
Semin Arthritis Rheum; 2022 Aug; 55():152018. PubMed ID: 35523066
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of leflunomide in the management of large vessel vasculitis: A systematic review and metaanalysis of cohort studies.
Narváez J; Estrada P; LLop D; Vidal-Montal P; Brugarolas E; Maymó-Paituvi P; Palacios-Olid J; Nolla JM
Semin Arthritis Rheum; 2023 Apr; 59():152166. PubMed ID: 36645992
[TBL] [Abstract][Full Text] [Related]
7. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC).
Sun Y; Wu B; Zhang W; Ma L; Kong X; Chen H; Jiang L
Ther Adv Chronic Dis; 2023; 14():20406223231158567. PubMed ID: 36895331
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study.
Peron Filho F; Moreira AS; Janes ALF; de Souza AWS
RMD Open; 2024 Mar; 10(1):. PubMed ID: 38443091
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
[TBL] [Abstract][Full Text] [Related]
11. Treatment of Pediatric Takayasu arteritis with infliximab and cyclophosphamide: experience from an American-Brazilian cohort study.
Stern S; Clemente G; Reiff A; Ramos MP; Marzan KA; Terreri MT
J Clin Rheumatol; 2014 Jun; 20(4):183-8. PubMed ID: 24847743
[TBL] [Abstract][Full Text] [Related]
12. Leflunomide in Takayasu arteritis - A long term observational study.
de Souza AW; de Almeida Agustinelli R; de Cinque Almeida H; Oliveira PB; Pinheiro FA; Oliveira AC; Sato EI
Rev Bras Reumatol Engl Ed; 2016; 56(4):371-5. PubMed ID: 27476631
[TBL] [Abstract][Full Text] [Related]
13. Leflunomide in Takayasu arteritis - A long term observational study.
de Souza AW; de Almeida Agustinelli R; de Cinque Almeida H; Oliveira PB; Pinheiro FA; Oliveira AC; Sato EI
Rev Bras Reumatol; 2016 Feb; ():. PubMed ID: 26924006
[TBL] [Abstract][Full Text] [Related]
14. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of proliferative lupus nephritis with leflunomide and steroid: a prospective multi-center controlled clinical trial].
Cui TG; Hou FF; Ni ZH; Chen XM; Zhang FS; Zhu TY; Zhao XZ; Bao CD; Zhao MH; Wang GB; Qian JQ; Cai GY; Li YN; Lu FM; Mei CL; Zou WZ; Wang HY
Zhonghua Nei Ke Za Zhi; 2005 Sep; 44(9):672-6. PubMed ID: 16202258
[TBL] [Abstract][Full Text] [Related]
16. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
de Boysson H; Boutemy J; Creveuil C; Ollivier Y; Letellier P; Pagnoux C; Bienvenu B
Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
[TBL] [Abstract][Full Text] [Related]
17. Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Utilization of Leflunomide in the Treatment of Rheumatoid Arthritis Trial Investigator Group.
Cohen S; Cannon GW; Schiff M; Weaver A; Fox R; Olsen N; Furst D; Sharp J; Moreland L; Caldwell J; Kaine J; Strand V
Arthritis Rheum; 2001 Sep; 44(9):1984-92. PubMed ID: 11592358
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India.
Goel R; Danda D; Joseph G; Ravindran R; Kumar S; Jayaseelan V; Jayaseelan L; Bacon P
Semin Arthritis Rheum; 2018 Apr; 47(5):718-726. PubMed ID: 29096935
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy.
Li Y; Xiong Y; Huang T; Liu X; Xu G
BMC Nephrol; 2021 Nov; 22(1):364. PubMed ID: 34736419
[TBL] [Abstract][Full Text] [Related]
20. Certolizumab pegol in the treatment of Takayasu arteritis.
Novikov PI; Smitienko IO; Sokolova MV; Alibaz-Oner F; Kaymaz-Tahra S; Direskeneli H; Moiseev SV
Rheumatology (Oxford); 2018 Dec; 57(12):2101-2105. PubMed ID: 30010945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
